Neil Kumar - Net Worth and Insider Trading
Neil Kumar Net Worth
The estimated net worth of Neil Kumar is at least $3.2 Billion dollars as of 2024-10-02. Neil Kumar is the CEO, 10% Owner of Eidos Therapeutics Inc and owns about 24,575,501 shares of Eidos Therapeutics Inc (EIDX) stock worth over $3.0 Billion. Neil Kumar is also the CEO of BridgeBio Pharma Inc and owns about 6,905,851 shares of BridgeBio Pharma Inc (BBIO) stock worth over $173 Million. Details can be seen in Neil Kumar's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Neil Kumar has not made any transactions after 2024-08-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Neil Kumar
Neil Kumar Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Neil Kumar owns 3 companies in total, including BridgeBio Pharma Inc (BBIO) , Eidos Therapeutics Inc (EIDX) , and LianBio (LIANY) .
Click here to see the complete history of Neil Kumar’s form 4 insider trades.
Insider Ownership Summary of Neil Kumar
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| BBIO | BridgeBio Pharma Inc | 2024-08-19 | director & See Remarks |
| EIDX | Eidos Therapeutics Inc | 2019-07-03 | director & 10 percent owner & Chief Executive Officer |
| LIANY | LianBio | 2021-10-29 | director |
Neil Kumar Latest Holdings Summary
Neil Kumar currently owns a total of 2 stocks. Among these stocks, Neil Kumar owns 24,575,501 shares of Eidos Therapeutics Inc (EIDX) as of July 3, 2019, with a value of $3.0 Billion and a weighting of 94.55%. Neil Kumar also owns 6,905,851 shares of BridgeBio Pharma Inc (BBIO) as of August 19, 2024, with a value of $173 Million and a weighting of 5.45%.
Latest Holdings of Neil Kumar
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EIDX | Eidos Therapeutics Inc | 2019-07-03 | 24,575,501 | 122.21 | 3,003,371,977 |
| BBIO | BridgeBio Pharma Inc | 2024-08-19 | 6,905,851 | 25.05 | 172,991,568 |
Holding Weightings of Neil Kumar
Neil Kumar Form 4 Trading Tracker
According to the SEC Form 4 filings, Neil Kumar has made a total of 0 transactions in Eidos Therapeutics Inc (EIDX) over the past 5 years. The most-recent trade in Eidos Therapeutics Inc is the acquisition of 882,353 shares on July 3, 2019, which cost Neil Kumar around $26 Million.
According to the SEC Form 4 filings, Neil Kumar has made a total of 26 transactions in BridgeBio Pharma Inc (BBIO) over the past 5 years, including 0 buys and 26 sells. The most-recent trade in BridgeBio Pharma Inc is the sale of 27,389 shares on August 19, 2024, which brought Neil Kumar around $676,234.
Insider Trading History of Neil Kumar
- 1
Neil Kumar Trading Performance
GuruFocus tracks the stock performance after each of Neil Kumar's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Neil Kumar is 1.71%. GuruFocus also compares Neil Kumar's trading performance to market benchmark return within the same time period. The performance of stocks bought by Neil Kumar within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Neil Kumar's insider trading performs compared to the benchmark.
Performance of Neil Kumar
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -7.03 | | | | | |
| Relative Return to S&P 500(%) | -8.3 | | | | | |
Neil Kumar Ownership Network
Neil Kumar Owned Company Details
What does BridgeBio Pharma Inc do?
Who are the key executives at BridgeBio Pharma Inc?
Neil Kumar is the director & See Remarks of BridgeBio Pharma Inc. Other key executives at BridgeBio Pharma Inc include 10 percent owner Kkr Genetic Disorder L.p. , See Remarks Brian C Stephenson , and Chairman of Oncology Frank Mccormick .
BridgeBio Pharma Inc (BBIO) Insider Trades Summary
Over the past 18 months, Neil Kumar made 6 insider transaction in BridgeBio Pharma Inc (BBIO) with a net sale of 422,045. Other recent insider transactions involving BridgeBio Pharma Inc (BBIO) include a net sale of 194,376 shares made by Brian C Stephenson , a net sale of 12,000 shares made by Randal W Scott , and a net sale of 8,745 shares made by Hannah Valantine .
In summary, during the past 3 months, insiders sold 5,831,544 shares of BridgeBio Pharma Inc (BBIO) in total and bought 0 shares, with a net sale of 5,831,544 shares. During the past 18 months, 8,037,166 shares of BridgeBio Pharma Inc (BBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 8,037,166 shares.
BridgeBio Pharma Inc (BBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.
BridgeBio Pharma Inc Insider Transactions
Neil Kumar Mailing Address
Above is the net worth, insider trading, and ownership report for Neil Kumar. You might contact Neil Kumar via mailing address: C/o Bridgebio Pharma, Inc., 3160 Porter Dr, Ste 250, Palo Alto Ca 94304.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
